Sandu Pharmaceuticals Ltd — Important, 07-01-2026: Company Update

The company has filed its compliance certificate under SEBI (DP) Regulation 2015 for the quarter ended 31.12.2025. This confirms that all dematerialization and rematerialization requests from shareholders were processed efficiently by the Registrar and Share Transfer Agent. It also certifies that physical share certificates received for dematerialization during the period were promptly destroyed after due verification. This ensures adherence to investor protection norms regarding share transfer facilities and maintaining the integrity of share records.